Claris Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$541K Hold
451
0.14% 43
2026
Q1
$415K Sell
451
-4
-0.9% -$4.05K 0.12% 48
2025
Q4
$489K Buy
455
+3
+0.7% +$2.87K 0.15% 42
2025
Q3
$352K Hold
452
0.12% 52
2025
Q2
$352K Sell
452
-94
-17% -$73K 0.12% 52
2025
Q1
$451K Hold
546
0.17% 47
2024
Q4
$422K Sell
546
-119
-18% -$98.5K 0.16% 43
2024
Q3
$589K Buy
+665
New +$598K 0.26% 31

Other funds holding LLY

Claris Advisors's LLY Position: Q2 2026 in Review

Claris Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 451 shares worth $541K. The position accounts for 0.14% of the portfolio, ranked #43.

Claris Advisors first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. The position peaked at $589K in Q3 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Claris Advisors held 451 shares of Eli Lilly worth $541K as of Q2 2026.
  • Claris Advisors left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.14% of Claris Advisors's portfolio in Q2 2026, its #43 holding.
  • Claris Advisors first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
  • Claris Advisors's Eli Lilly position peaked at $589K in Q3 2024.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Claris Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.